These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 8713623)
1. [Genotoxic and mutagenic activity of antineoplastic anthracyclines and their aglycones: study in two test-systems]. Vasil'eva SV; Makhova EV; Efremenkova OV; Bartoshevich IuE Genetika; 1996 Feb; 32(2):233-9. PubMed ID: 8713623 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of anthracycline-induced genotoxicity in vitro. Westendorf J; Marquardt H; Marquardt H Cancer Res; 1984 Dec; 44(12 Pt 1):5599-604. PubMed ID: 6388827 [TBL] [Abstract][Full Text] [Related]
3. SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency. White PA; Rasmussen JB Environ Mol Mutagen; 1996; 27(4):270-305. PubMed ID: 8665872 [TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of aclacinomycin A and daunomycin derivatives. Umezawa K; Sawamura M; Matsushima T; Sugimura T Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304 [TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system. Umezawa K; Haresaku M; Muramatsu M; Matsushima T Biomed Pharmacother; 1987; 41(5):214-8. PubMed ID: 2444280 [TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests. Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017 [TBL] [Abstract][Full Text] [Related]
7. Genetic and physiological modulation of anthracycline-induced mutagenesis in Salmonella typhimurium. Cebula TA Environ Mutagen; 1986; 8(5):675-92. PubMed ID: 3533526 [TBL] [Abstract][Full Text] [Related]
8. Genotoxic activity of 3-[3-phenyl-1,2,4-oxadiazol-5-yl] propionic acid and its peptidyl derivatives determined by Ames and SOS response tests. Leite AC; Vieira RF; de M Moreira DR; Brondani DJ; Srivastava RM; da Silva VF; de Morais Júnior MA Mutat Res; 2005 Dec; 588(2):166-71. PubMed ID: 16325458 [TBL] [Abstract][Full Text] [Related]
9. Genotoxic evaluation of extracts from Aplysina fulva, a Brazilian marine sponge. Aiub C; Giannerini A; Ferreira F; Mazzei J; Stankevicins L; Lobo-Hajdu G; Guimarães P; Hajdu E; Felzenszwalb I Mutat Res; 2006 Dec; 611(1-2):34-41. PubMed ID: 16987694 [TBL] [Abstract][Full Text] [Related]
10. [A comparative analysis of mutagenic and SOS-induced activity in three classes of chemical compounds]. Vasil'eva SV; Tanirbergenov TB; Abilev SK; Migachev GI Genetika; 1989 Oct; 25(10):1740-6. PubMed ID: 2695388 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines. Chłopkiewicz B; Ejchart A; Marczewska J; Anuszewska E; Priebe W Acta Pol Pharm; 2005; 62(2):99-104. PubMed ID: 16161349 [TBL] [Abstract][Full Text] [Related]
12. Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents. Bhuyan BK; Zimmer DM; Mazurek JH; Trzos RJ; Harbach PR; Shu VS; Johnson MA Cancer Res; 1983 Nov; 43(11):5293-7. PubMed ID: 6225515 [TBL] [Abstract][Full Text] [Related]
13. Genotoxicity of 5-aminolevulinic and 4,5-dioxovaleric acids in the salmonella/microsuspension mutagenicity assay and SOS chromotest. Onuki J; Rech CM; Medeiros MH; de A Umbuzeiro G; Di Mascio P Environ Mol Mutagen; 2002; 40(1):63-70. PubMed ID: 12211078 [TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium. Marzin D; Jasmin C; Maral R; Mathe G Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters. Glowienke S; Frieauff W; Allmendinger T; Martus HJ; Suter W; Mueller L Mutat Res; 2005 Mar; 581(1-2):23-34. PubMed ID: 15725602 [TBL] [Abstract][Full Text] [Related]
16. A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity. Andrivon W; Callais F; Nafziger J; Monneret C; Guillosson JJ Mutat Res; 1995 Oct; 344(3-4):135-40. PubMed ID: 7491131 [TBL] [Abstract][Full Text] [Related]
17. Impact of a point mutation in the muc region of plasmid pKM101 on anthracycline-induced mutagenesis in Salmonella typhimurium. Cole JA; Thomas HF Environ Mutagen; 1985; 7(1):129-33. PubMed ID: 3881252 [No Abstract] [Full Text] [Related]
18. [Characteristics of the mutagenic and toxic effects of ethylene imine and its oligomers. Comparative study in the automated SOS-chromotest system and in standard bacterial test systems]. Tanirbergenov TB; Vasil'eva SV; Kostianovskiĭ RG; Rappoport IA; Huttunen T Genetika; 1988 Apr; 24(4):763-5. PubMed ID: 3294106 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX. Sturdíková M; Fusková A; Prikrylová V; Podojil M; Fuska J Neoplasma; 1986; 33(3):297-305. PubMed ID: 2426609 [TBL] [Abstract][Full Text] [Related]